PATENT CLAIM ANALYSIS

Application Number: 15895699
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["424", "085200"]

Abstract:
The invention provides a pharmaceutical composition including a peptide comprising at least a portion of a chemokine receptor or a G-protein coupled receptor and optionally a cytokine. The pharmaceutical composition of the invention may be used for altering immune system functioning, for example, to treat an immune system disorder, such as an autoimmune disease, multiple sclerosis, transplant rejection, psoriasis and asthma. The invention also provides peptides that may be used in the pharmaceutical composition and a method for preparing the pharmaceutical composition of the invention. The invention further provides a method for to treating an immune system disorder, such as an autoimmune disease, multiple sclerosis, transplant rejection, and psoriasis asthma.

Claim (Index 39):
A pharmaceutical composition comprising:\n (a) a cytokine; (b) a peptide consisting of at least a portion of a cytokine receptor or a G-protein coupled receptor (GPCR); and (c) a physiologically acceptable carrier.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 2.25455
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15236829', '14257447', '12225122', '12870573', '09792793']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7349888047341954
- 35 USC 102 Novelty (BERT): 0.673532641127862
- Combined Prediction Score: 0.728843188373562
- Mean Citation Score: 606.738736
- Max Citation Score: 871.6447
- Similarity Product: 631.4036645475862

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test